Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Oct 18 2023
Business
Oct 18 2023
4 min read

Press Release Oct 18 2023

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 18, 2023, titled "Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities".

View Attachment